Literature DB >> 19730208

Clinical study of low back pain and radicular pain pathways by using l2 spinal nerve root infiltration: a randomized, controlled, clinical trial.

Yasuaki Murata1, Yoshiharu Kato, Kazuhisa Miyamoto, Kazuhisa Takahashi.   

Abstract

STUDY
DESIGN: Randomized control trial (RCT) for L2 spinal nerve infiltration (L2 block) in clinical cases.
OBJECTIVES: To confirm or refute the effect of L2 block using RCT, and to study the pathway of low back pain (LBP) and radicular pain in clinical cases. SUMMARY OF BACKGROUND DATA: It has been reported in animal experiments that one of the main pathways of pain originating from the lumbar spine is the sympathetic trunk through the L2 spinal nerve rootvia sympathetic afferents.
METHODS: To evaluate the effectiveness of L2 block, patients who had LBP and were treated with nonsteroidal anti-inflammatory drugs for at least 2 weeks were then randomized to the L2 block or control block groups. The intensities of LBP and radicular pain were measured using visual analog scale and face scale before and at 5 minutes and 7 days after the injection. These values were compared, and the effects of the injections on the pain pathway were studied.
RESULTS: The average visual analog scale scores for LBP before and at 5 minutes and 7 days after the injection were 69, 14, and 44 mm in the L2 block group and 68, 62, and 59 mm in the control block group, respectively. After L2 block, 28 patients reported adequate therapeutic effect at 10 weeks, and the effect lasted for more than 24 weeks in 10 of these patients. After control block, 9 patients reported adequate therapeutic effect at 10 and 24 weeks.
CONCLUSION: The LBP and radicular pain pathways were likely interrupted by L2 block. An L2 block is useful in reducing LBP due to the disorders of L2 spinal nerve-innervated structures, such as the disc, facet joint, and sacroiliac joint. However, the therapeutic value of an L2 block may be occasionally insufficient to alleviate pain completely because of the short duration of its' effect.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19730208     DOI: 10.1097/BRS.0b013e3181b1fb96

Source DB:  PubMed          Journal:  Spine (Phila Pa 1976)        ISSN: 0362-2436            Impact factor:   3.468


  6 in total

1.  The effectiveness of L2 nerve root block for the management of patients who are suffering from chronic low back and referred pain.

Authors:  Hyung-Woo Lim; Yong-Hyun Cho; Sun-Hee Kim; Dong-Hyun Lee; Seung-Hyun Kang
Journal:  Korean J Anesthesiol       Date:  2013-08

2.  Bilateral ultrasound-guided erector spinae plane block for postoperative persistent low back pain in lumbar disc surgery.

Authors:  Mehmet Emin Akyuz; Mustafa Nevzat Firidin
Journal:  Eur Spine J       Date:  2022-04-14       Impact factor: 2.721

3.  Chronic Orchialgia Stemming From Lumbar Disc Herniation: A Case Report and Brief Review.

Authors:  Eric Chun Pu Chu; Arnold Yu Lok Wong
Journal:  Am J Mens Health       Date:  2021 May-Jun

4.  The effect of impregnated autogenous epidural adipose tissue with bupivacaine, methylprednisolone acetate or normal saline on postoperative radicular and low back pain in lumbar disc surgery under spinal anesthesia; A randomized clinical trial study.

Authors:  Saeid Abrishamkar; Ahmad Reza Rafiei; Masih Sabouri; Siamak Moradi; Homayoun Tabesh; Payman Rahmani; Ali Hekmatnia; Mostafa Torkashvand; Noorolah Eshraghi; Ghasem Baghershahi
Journal:  J Res Med Sci       Date:  2011-05       Impact factor: 1.852

5.  Neuropathic pain in elderly patients with chronic low back painand effects of pregabalin: a preliminary study.

Authors:  Yoshihito Sakai; Kenyu Ito; Tetsuro Hida; Sadayuki Ito; Atsushi Harada
Journal:  Asian Spine J       Date:  2015-04-15

6.  Clinical Features of Thoracic Myelopathy: A Single-Center Study.

Authors:  Kei Ando; Shiro Imagama; Kazuyoshi Kobayashi; Kenyu Ito; Mikito Tsushima; Masayoshi Morozumi; Satoshi Tanaka; Masaaki Machino; Kyotaro Ota; Hiroaki Nakashima; Yoshihiro Nishida; Naoki Ishiguro
Journal:  J Am Acad Orthop Surg Glob Res Rev       Date:  2019-11-04
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.